LG conducts Phase II trials for new antidiabetic agent
Results of Phase I trial in 90 diabetic patients, conducted in Seoul National University Hospital, demonstrated the efficacy and safety of LC15-0444, acc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
